The dynamic role of immune checkpoint molecules in diagnosis, prognosis, and treatment of head and neck cancers

<p>Head and neck cancer (HNC) is the sixth most common cancer type, accounting for approximately 277,597 deaths worldwide. Recently, the Food and Drug Administration (FDA) has approved immune checkpoint blockade (ICB) agents targeting programmed death-1 (PD-1) and programmed death-ligand 1 (PD...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Sarra Mestiri (14557379) (author)
مؤلفون آخرون:	Dina Moustafa Abo El-Ella (18394866) (author), Queenie Fernandes (14557388) (author), Takwa Bedhiafi (14153460) (author), Salam Almoghrabi (15263539) (author), Shayista Akbar (14442117) (author), Varghese Inchakalody (15263530) (author), Laila Assami (17821421) (author), Shaheena Anwar (19325623) (author), Shahab Uddin (154400) (author), Abdul Rehman Zar Gul (14442126) (author), Mariam Al-Muftah (365985) (author), Maysaloun Merhi (4246147) (author), Afsheen Raza (492657) (author), Said Dermime (79420) (author)
منشور في:	2024
الموضوعات:	Biomedical and clinical sciences Clinical sciences Immunology Oncology and carcinogenesis Head and neck cancer Immune checkpoint molecules Stimulatory and inhibitory biomarkers Diagnosis And prognosis biomarkers
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

The dynamic role of immune checkpoint molecules in diagnosis, prognosis, and treatment of head and neck cancers

مواد مشابهة